Background and Objectives: In patients with acute heart failure (AHF), there is no definite evidence on the relationship between high-sensitivity cardiac troponin (hs-cTnI) and the left ventricular ejection fraction (LVEF) comparing the reduced and preserved EF conditions. Materials and Methods: Between January and April 2022, we retrospectively analyzed the data from 386 patients admitted to the emergency departments (ED) of five hospitals in Rome, Italy, for AHF. The criteria for inclusion were a final diagnosis of AHF; a cardiac ultrasound and hs-cTnI evaluations in the ED; and age > 18 yrs. We excluded patients with acute coronary syndrome (ACS). Based on echocardiography and hs-cTnI evaluations, the patients were grouped for (1) preserved (HFpEF) or (2) reduced LVEF (HFrEF) and a a) negative (within the normal range value) or b) positive (above the normal range value) of hs-cTnI, respectively. Results: There was a significant negative relationship between a positive test for hs-cTnI and LVEF. When compared to the group with a negative hs-cTnI test, the patients with a positive test, both from the HFpEF and HFrEF subgroups, were significantly more likely to have an adverse outcome, such as being admitted to the intensive care unit (ICU) or dying in the ED. Moreover, a reduced ejection fraction was linked with a final disposition to a higher level of care. Conclusions: In patients admitted to the ED for AHF without ACS, there is a negative relationship between hs-cTnI and a reduced LVEF, although a significant percentage of patients with a preserved LVEF also resulted to have high levels of hs-cTnI. In the absence of ACS, hs-cTnI seems to be a reliable biomarker of myocardial injury in AHF in the ED and should be considered as a risk stratification parameter for these subjects regardless of the left ventricular function. Further larger prospective studies are needed to confirm these preliminary data.

Usefulness of High-Sensitivity Troponin I in Risk Stratification and Final Disposition of Patients with Acute Heart Failure in the Emergency Department. Comparison between HFpEF vs. HFrEF / Crisanti, Luca; Valli, Gabriele; Cennamo, Elisa; Capolino, Alessandro; Fratini, Paolo; Cesaro, Claudio; Adducchio, Gloria; De Magistris, Antonio; Terlizzi, Ferdinando; Ruggieri, Maria Pia; Mirante, Enrico; Savoriti, Claudio; Sukruang, Kalyarat; Valeriano, Valentina; Pugliese, Francesco Rocco; Travaglino, Francesco; Di Somma, Salvatore. - In: MEDICINA. - ISSN 1010-660X. - 59:1(2022), pp. 1-9. [10.3390/medicina59010007]

Usefulness of High-Sensitivity Troponin I in Risk Stratification and Final Disposition of Patients with Acute Heart Failure in the Emergency Department. Comparison between HFpEF vs. HFrEF

Crisanti, Luca;Cennamo, Elisa;Capolino, Alessandro;Fratini, Paolo;Cesaro, Claudio;Adducchio, Gloria;De Magistris, Antonio;Terlizzi, Ferdinando;Ruggieri, Maria Pia;Mirante, Enrico;Savoriti, Claudio;Pugliese, Francesco Rocco;Di Somma, Salvatore
2022

Abstract

Background and Objectives: In patients with acute heart failure (AHF), there is no definite evidence on the relationship between high-sensitivity cardiac troponin (hs-cTnI) and the left ventricular ejection fraction (LVEF) comparing the reduced and preserved EF conditions. Materials and Methods: Between January and April 2022, we retrospectively analyzed the data from 386 patients admitted to the emergency departments (ED) of five hospitals in Rome, Italy, for AHF. The criteria for inclusion were a final diagnosis of AHF; a cardiac ultrasound and hs-cTnI evaluations in the ED; and age > 18 yrs. We excluded patients with acute coronary syndrome (ACS). Based on echocardiography and hs-cTnI evaluations, the patients were grouped for (1) preserved (HFpEF) or (2) reduced LVEF (HFrEF) and a a) negative (within the normal range value) or b) positive (above the normal range value) of hs-cTnI, respectively. Results: There was a significant negative relationship between a positive test for hs-cTnI and LVEF. When compared to the group with a negative hs-cTnI test, the patients with a positive test, both from the HFpEF and HFrEF subgroups, were significantly more likely to have an adverse outcome, such as being admitted to the intensive care unit (ICU) or dying in the ED. Moreover, a reduced ejection fraction was linked with a final disposition to a higher level of care. Conclusions: In patients admitted to the ED for AHF without ACS, there is a negative relationship between hs-cTnI and a reduced LVEF, although a significant percentage of patients with a preserved LVEF also resulted to have high levels of hs-cTnI. In the absence of ACS, hs-cTnI seems to be a reliable biomarker of myocardial injury in AHF in the ED and should be considered as a risk stratification parameter for these subjects regardless of the left ventricular function. Further larger prospective studies are needed to confirm these preliminary data.
2022
acute heart failure; emergency department; high-sensitivity troponin I; left ventricular ejection fraction; risk stratification
01 Pubblicazione su rivista::01a Articolo in rivista
Usefulness of High-Sensitivity Troponin I in Risk Stratification and Final Disposition of Patients with Acute Heart Failure in the Emergency Department. Comparison between HFpEF vs. HFrEF / Crisanti, Luca; Valli, Gabriele; Cennamo, Elisa; Capolino, Alessandro; Fratini, Paolo; Cesaro, Claudio; Adducchio, Gloria; De Magistris, Antonio; Terlizzi, Ferdinando; Ruggieri, Maria Pia; Mirante, Enrico; Savoriti, Claudio; Sukruang, Kalyarat; Valeriano, Valentina; Pugliese, Francesco Rocco; Travaglino, Francesco; Di Somma, Salvatore. - In: MEDICINA. - ISSN 1010-660X. - 59:1(2022), pp. 1-9. [10.3390/medicina59010007]
File allegati a questo prodotto
File Dimensione Formato  
Crisanti_Usefulness-of High-Sensitivity-Troponin_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 630.67 kB
Formato Adobe PDF
630.67 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1679226
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 3
social impact